«This finding really excites us because it makes us think that this is a gene repair system that could be used to
treat a range of diseases — not just
tyrosinemia but others as well,» says Daniel Anderson, associate professor in MIT's Department of Chemical Engineering and a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES).